Transcriptomics

Dataset Information

0

Over-expression of BAG-1 in head and neck squamous cell carcinomas (HNSCC) is associated with cisplatin-resistance


ABSTRACT: In order to improve therapy for head and neck squamous cell carcinoma (HNSCC), biomarkers associated with local and/or distant tumor relapses and cancer drug resistance are urgently needed. This study identified a potential biomarker, BAG-1 (Bcl-2 associated athanogene-1), that is implicated in HNSCC insensitive to cisplatin and tumor progression. Advanced HNSCC cells revealed resistant to cisplatin accompanied by increased expression of BAG-1 protein. siRNA knockdown of BAG-1 expression resulted in significant improvement of HNSCC sensitivity to cisplatin. BAG-1 expression enhanced stability of BCL-xL and conferred cisplatin resistant to the HNSCC cells. In addition, high levels of expression of phospho AKT, BAG-1, and BCL- xL were observed in advanced HNSCC compared to in that of primary HNSCC. Conclusion: Increased expression of BAG-1 was associated with cisplatin resistance and tumor progression in HNSCC patients and warrants further validation in larger independent studies. Over expression of BAG-1 may be a biomarker for cisplatin resistance in patients with primary or recurrent HNSCCs and targeting BAG-1 could be helpful in overcoming cisplatin resistance.

ORGANISM(S): Homo sapiens

PROVIDER: GSE102787 | GEO | 2017/10/04

SECONDARY ACCESSION(S): PRJNA398680

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-06-04 | GSE199240 | GEO
2024-06-17 | GSE270030 | GEO
2020-11-27 | GSE141572 | GEO
2020-11-28 | PXD022799 |
2013-02-01 | E-MTAB-966 | biostudies-arrayexpress
2017-03-30 | E-MTAB-5198 | biostudies-arrayexpress
2022-06-15 | GSE173618 | GEO
2016-10-25 | E-MTAB-4854 | biostudies-arrayexpress
2022-07-07 | GSE202030 | GEO
2021-12-22 | GSE159504 | GEO